HF 3652
Introduction - 94th Legislature (2025 - 2026)
Posted on 03/18/2026 01:02 p.m.
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14
1.15 1.16
A bill for an act
relating to health insurance; limiting cost-sharing for epilepsy-related prescription
drugs and medical supplies; amending Minnesota Statutes 2024, section 62Q.481,
subdivision 2.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
Section 1.
Minnesota Statutes 2024, section 62Q.481, subdivision 2, is amended to read:
Subd. 2.
Definitions.
(a) For purposes of this section, the following definitions apply.
(b) "Chronic disease" means diabetes, asthma,new text begin epilepsy,new text end and allergies requiring the use
of epinephrine auto-injectors.
(c) "Cost-sharing" means co-payments and coinsurance.
(d) "Related medical supplies" means syringes, insulin pens, insulin pumps, test strips,
glucometers, continuous glucose monitors, epinephrine auto-injectors, asthma inhalers, and
other medical supply items necessary to effectively and appropriately treat a chronic disease
or administer a prescription drug prescribed to treat a chronic disease.
new text begin EFFECTIVE DATE. new text end
new text begin
This section is effective January 1, 2027, and applies to health
plans offered, issued, or renewed on or after that date.
new text end